279
Participants
Start Date
June 14, 2021
Primary Completion Date
November 15, 2024
Study Completion Date
May 15, 2025
At-home natalizumab treated MS patient
"MS patient who are treated with natalizumab in at-home hospitalization (HAD) setting / according at-home hospitalization program"
Marseille University Hospital, Marseille
Quimper Hospital, Quimper
Brest University Hospital, Brest
Toulouse University Hospital, Toulouse
Bordeaux University Hospital, Bordeaux
Libourne Hospital, Libourne
Montpellier University Hospital, Montpellier
Rennes University Hospital, Rennes
Tours University Hospital, Tours
CHU Grenoble Alpes, La Tronche
Dax Hospital, Dax
Nantes University Hospital, Nantes
Orléans Hospital, Orléans
Lille University Hospital, Lille
Hôpital St Vincent de Paul, Lille
Strasbourg University Hospital, Strasbourg
Adolphe de Rothschild Ophthalmological Foundation, Paris
AP-HP La Pitié-Salpêtrière Hospital, Paris
Rouen University Hospital, Rouen
Poitiers University Hospital, Poitiers
Limoges University Hospital, Limoges
Percy Army Training Hospital, Clamart
CH Ajaccio, Ajaccio
Les Hôpitaux de Chartres, Chartres
Rennes University Hospital
OTHER
Nantes University Hospital
OTHER